The Ethics of Characterizing Difference: Guiding Principles on Using Racial
Categories in Human Genetics
By Sandra Soo-Jin Lee et. al.,
Genome Biology
| 07. 15. 2008
Abstract
We are a multidisciplinary group of Stanford faculty who propose ten principles to guide the use of racial and ethnic categories when characterizing group differences in research into human genetic variation.
Open letter
Since the completion of the Human Genome Project, research focused on human genetic variation, including differences among groups, has intensified. This focus has rekindled debates about the connection between genetic (DNA-level) traits and human 'racial' difference [1-5]. Scholars are divided on the question of whether racial categorization is an appropriate means of organizing potentially useful genetic data or a pernicious reification of historically destructive typologies [6,7]. To explore these issues, faculty from the humanities, social sciences, life sciences, law and medicine at Stanford University convened over the past few years to engage in an extended interdisciplinary dialog. The initial meeting consisted of a two-day workshop in 2003 that developed into an ongoing faculty research seminar sponsored by the Stanford Humanities Center, Affymetrix Corporation, the Mellon Foundation and the Research Institute of the Center for Comparative Studies on Race and Ethnicity. This seminar series, which continued for...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...